FULT Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Expectations Novo Nordisk AS NVO Q1 2026 Earnings Strong EPS Beat Driven by Obesity and Diabetes Portfolio SGMT Q1 2026 Earnings EPS Beat as Clinical Development Costs Tighten PMTU Q1 2026 Earnings EPS Falls Short of Expectations Revenue Data Unavailable VTEX Q1 2026 Earnings EPS Misses Estimates as Stock Declines Runway Growth Finance Corp RWAYI Q1 2026 Earnings EPS Miss as Net Investment Income Falls Short